This is a historical report — it no longer reflects this drug's current status. Current status: Active Shortage. View this drug's full profile page →
MAVIK
BGP PHARMA ULC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of MAVIK in Canada?
Yes. MAVIK 1MG has an active shortage reported to Health Canada (last updated September 3, 2026).
Why is MAVIK not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will MAVIK be available again?
The manufacturer's estimated resolution date is October 13, 2026. This is an estimate and can change; follow this page to get an email when the status changes.
What this means
Does this mean the shortage is completely over everywhere?
It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.
What should I do?
If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.
DIN
02231459
Strength
1MG
Dosage Form
CAPSULE
Route
ORAL
Active Ingredient
TRANDOLAPRIL
Tier
Unrated
Last Updated
2018-11-08
Reason for Shortage
Delay in shipping of the drug.
Past Reports for This Drug
MAVIK has 2 shortage/discontinuation reports on file — this is one of them.
Other Products from BGP PHARMA ULC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.